Title Page -- Table of Contents -- Section 1: The basic tools -- Terminology and Glossary -- Lesions -- Investigation and diagnosis -- 3.1 History -- 3.2 Clinical Examination -- 3.3 Examination For Ectoparasites -- 3.4 Cytology -- 3.5 Skin biopsies -- 3.6 Fungal examination -- 3.7 Examinations for bacteria and yeasts -- 3.8 Allergy testing -- 3.9 Tests for endocrine disease -- Section 2: Problem-orientated approach -- The pruritic patient -- 4.1 Causes of pruritus -- 4.2 The pruritic dog -- 4.3 The more mature patient -- 4.4 The pruritic cat -- 4.5 Clinical approach to the pruritic cat -- The scaling patient -- 5.1 The most common cause of scaling conditions is parasites -- 5.2 Localisation of scaling disorders -- 5.3 Dermatophytosis -- 5.4 Bacterial and yeast infections -- 5.5 Systemic disease -- 5.6 Endocrine disease -- 5.7 Mild scaling -- 5.8 Biopsy -- 5.9 Immune-mediated disease -- 5.10 Primary genetic scaling disorders -- 5.11 Hypersensitivity dermatitis -- 5.12 Treatment of scaling disorders -- The alopecic patient -- 6.1 Congenital or inherited hairloss -- 6.2 Pattern alopecias -- 6.3 Traumatic hairloss -- 6.4 Inflammatory hairloss -- 6.5 Screen for alopecia due to systemic disease -- 6.6 Paraneoplastic alopecia -- 6.7 Endocrine alopecia -- 6.8 Biopsy -- 6.9 Non-endocrine alopecias -- 6.10 Long-term palliative treatment is usually necessary in alopecic skin conditions to address secondary complications (see chapter 27) -- Management of diseases presenting with spots (papules, pustules, vesicles and bullae) -- 7.1 Young animals -- 7.2 Severe/recurrent or persistent lesions -- 7.3 Investigation of papular disease -- 7.4 Investigation of vesicular disease -- 7.5 Investigation of pustular disease -- 7.6 Folliculitis -- Approach to changes in pigmentation.

8.1 Changes in pigmentation may be generalised or may be localised in specific patterns -- 8.2 Secondary changes in pigmentation should be differentiated from primary changes -- 8.3 Generalised hyperpigmentation may occur in some endocrine and non-endocrine conditions -- 8.4 Pigmentary change may be benign and/or transient -- 8.5 Loss of pigmentation of the skin -- 8.6 Reddening of the skin -- 8.7 Increase in pigmentation -- 8.8 Loss of pigmentation of hair coat -- 8.9 Early histopathological examination is essential -- 8.10 Some lesions cannot always be definitively diagnosed on biopsy -- Management of raised and ulcerative skin lesions -- 9.1 Papular pustular and vesicular disease -- 9.2 Eosinophilic granuloma complex -- 9.3 Cytology or histopathology -- 9.4 Treatment of neoplastic disease -- 9.5 Raised lesions due to micro-organisms -- 9.6 Definitive diagnosis reached -- 9.7 Chronic inflammatory and bacterial/fungal lesions -- Section 3: Aetiological approach -- Diseases caused by ectoparasites -- 10.1 Dog -- 10.2 Cats -- 10.3 Rabbit -- 10.4 Guinea pigs -- 10.5 Other Mites And Lice Of Rabbits Mice And Gerbils(Figures 3.18b, 3.20b And 3.21) -- Skin disease caused by micro-organisms -- 11.1 Bacterial infections -- 11.2 Leishmaniosis -- 11.3 Fungal infections -- 11.4 Malassezia Dermatitis -- 11.5 Skin diseases caused by viruses -- Hypersensitivity dermatitis -- 12.1 Parasitic hypersensitivity -- 12.2 Atopic dermatitis -- 12.3 Adverse cutaneous reaction to food -- 12.4 Insect bite hypersensitivity -- 12.5 Bacterial, fungal and yeast hypersensitivity -- Management of immune-mediated disease -- 13.1 Types of immune-mediated disease -- 13.2 The management of immune-mediated disease -- 13.3 Specific diseases -- Endocrine disease -- 14.1 Hyperadrenocorticism -- 14.2 Hypothyroidism -- 14.3 Less common endocrine diseases with a primary effect on the skin.

14.4 Common endocrine diseases that have a secondary effect on the skin -- 14.5 Rare endocrine problems -- Disorders of the pilosebaceous unit (hair follicle disorders) -- 15.1 Primary hair follicle dysplasias -- 15.2 Secondary hair follicle dysplasias -- Neoplastic skin disease -- 16.1 Primary skin masses -- 16.2 Common types of skin neoplasia -- 16.3 Generalised skin neoplasia -- 16.4 Metastatic skin neoplasia -- 16.5 Paraneoplastic syndromes -- Other skin diseases -- 17.1 Metabolic disease -- 17.2 Nutritional disease -- 17.3 Environmental causes -- 17.4 Psychogenic dermatoses -- 17.5 Dermatoses of neurological origin -- Section 4: Anatomically localised skin disease -- The foot -- 18.1 Management of claw disease -- 18.2 Management of footpad disease -- 18.3 Pododermatitis -- Skin disease affecting the perianal region -- 19.1 Management of perianal skin disease -- Ear disease -- 20.1 Management of pinnal disease -- 20.2 Management of acute otitis externa (figure 20.7) -- 20.3 Management of chronic or recurrent otitis externa (figures 20.8 and 20.9) -- Periocular skin disease -- 21.1 management of periocular disease -- Dermatoses affecting the muzzle -- 22.1 management of the haired skin of the muzzle -- 22.2 management of diseases affecting the nasal planum -- Management of facial lesions -- Management of skin disease affecting the legs -- Management of diseases affecting mainly the trunk and dorsum -- Section 5: Treatment of skin diseases -- Treatment of primary skin disease -- 26.1 Ectoparasiticides -- 26.2 Treatment of diseases caused by micro-organisms -- 26.3 Treatment of hypersensitivity dermatitis -- 26.4 Treatment of immune-mediated disease -- 26.5 Treatment of endocrine disease -- 26.6 Treatments for hair follicle disorders and keratinisation defects (primary scaling disorders, primary seborrhoea).

26.7 Chemotherapeutic agents commonly used in skin neoplasia -- Treatment of presenting signs -- 27.1 Management of pruritus -- 27.2 Bacterial And Yeast Infections -- 27.3 Management of scaling -- 27.4 Nutritional support for damaged skin -- Use and abuse of glucocorticoids -- 28.1 Indications -- 28.2 Dose and formulation -- 28.3 Steroid sparing measures -- 28.4 Side-effects -- 28.5 Contraindications -- Topical treatments -- 29.1 Use of topical preparations -- 29.2 Inappropriate use of topical products can be harmful -- 29.3 Formulations of topical treatments -- Appendices -- Appendix 1: History form -- Appendix 2: Clinical examination -- Appendix 3: Testing food intolerance -- Appendix 4: Advice on the use of medicinal products -- Appendix 5: Safe use of glucocorticoids -- Appendix 6: Side-effects seen when steroids are given -- Index.